This resource is no longer available
A thought-leadership article by Kathryn Kolonic, DO, MPH, CPHQ , AllMedSM Vice President/Medical Director, highlighting the importance of specialized expertise in effectively managing orphan drug utilization for members with Medicare Part D coverage.
In this article, you’ll gain an understanding of the factors that influence Medicare Part D plan restrictions on orphan drugs. Drawing on the expertise of Medicare-trained, board-certified physicians to provide evidence-based, medically necessary determinations across all major specialties and subspecialties within a turnaround time to meet CMS guidelines can help ensure your members receive optimal, cost-effective care.
- Vendor:
- AllMed
- Posted:
- Aug 10, 2022
- Published:
- Jul 12, 2022
- Format:
- Type:
- White Paper
